Quantitative detection of macular microvascular abnormalities identified by optical coherence tomography angiography in different hematological diseases
(2024) In Scientific Reports 14(1).- Abstract
It is now understood that hematological diseases can have detrimental effects on the retina, reducing retinal capillaries, compromising visual function, and potentially causing irreversible visual impairment. Over the years, there has been limited research on macular microvascular abnormalities, such as changes in vessel density and the foveal avascular zone (FAZ) and variations in the severity of these effects across different types of blood disorders. This study aims to quantitatively assess the impact of various hematological disorders on the retina using optical coherence tomography angiography (OCTA). Compared with healthy eyes, patients with different blood diseases exhibited reductions in linear vessel density (LVD), perfusion... (More)
It is now understood that hematological diseases can have detrimental effects on the retina, reducing retinal capillaries, compromising visual function, and potentially causing irreversible visual impairment. Over the years, there has been limited research on macular microvascular abnormalities, such as changes in vessel density and the foveal avascular zone (FAZ) and variations in the severity of these effects across different types of blood disorders. This study aims to quantitatively assess the impact of various hematological disorders on the retina using optical coherence tomography angiography (OCTA). Compared with healthy eyes, patients with different blood diseases exhibited reductions in linear vessel density (LVD), perfusion vessel density (PVD), FAZ area, and FAZ perimeter. Notably, patients with erythrocyte diseases showed more significant abnormalities in LVD and PVD, while patients with lymphocytic diseases demonstrated more pronounced abnormalities in the FAZ area and perimeter. OCTA imaging could potentially reflect changes of the retinal microvascular of patients with hematological diseases and may serve as a valuable tool for distinguishing abnormalities affecting different blood cell lines. This approach offers a novel avenue for assessing, treating, and monitoring blood disorders.
(Less)
- author
- organization
- publishing date
- 2024-12
- type
- Contribution to journal
- publication status
- published
- subject
- keywords
- Erythrocyte diseases, Lymphocyte diseases, Myelocyte diseases, Optical coherence tomography angiography, Pancytopenia diseases
- in
- Scientific Reports
- volume
- 14
- issue
- 1
- article number
- 25433
- publisher
- Nature Publishing Group
- external identifiers
-
- scopus:85207629171
- pmid:39455721
- ISSN
- 2045-2322
- DOI
- 10.1038/s41598-024-76753-8
- language
- English
- LU publication?
- yes
- id
- b96d53f4-6e3d-46d2-9c66-59fc312bfda1
- date added to LUP
- 2024-12-03 12:25:13
- date last changed
- 2024-12-17 13:51:09
@article{b96d53f4-6e3d-46d2-9c66-59fc312bfda1, abstract = {{<p>It is now understood that hematological diseases can have detrimental effects on the retina, reducing retinal capillaries, compromising visual function, and potentially causing irreversible visual impairment. Over the years, there has been limited research on macular microvascular abnormalities, such as changes in vessel density and the foveal avascular zone (FAZ) and variations in the severity of these effects across different types of blood disorders. This study aims to quantitatively assess the impact of various hematological disorders on the retina using optical coherence tomography angiography (OCTA). Compared with healthy eyes, patients with different blood diseases exhibited reductions in linear vessel density (LVD), perfusion vessel density (PVD), FAZ area, and FAZ perimeter. Notably, patients with erythrocyte diseases showed more significant abnormalities in LVD and PVD, while patients with lymphocytic diseases demonstrated more pronounced abnormalities in the FAZ area and perimeter. OCTA imaging could potentially reflect changes of the retinal microvascular of patients with hematological diseases and may serve as a valuable tool for distinguishing abnormalities affecting different blood cell lines. This approach offers a novel avenue for assessing, treating, and monitoring blood disorders.</p>}}, author = {{Jian, Tianzi and Xu, Fabao and Li, Guihua and Song, Boxuan and Wang, Helei and Yang, Xueying and Zhai, Weibin and Li, Xiangchen and Li, Zhiwen and Feng, Qi and Xu, Shuqian and Semple, John W. and Zhang, Li and Peng, Jun}}, issn = {{2045-2322}}, keywords = {{Erythrocyte diseases; Lymphocyte diseases; Myelocyte diseases; Optical coherence tomography angiography; Pancytopenia diseases}}, language = {{eng}}, number = {{1}}, publisher = {{Nature Publishing Group}}, series = {{Scientific Reports}}, title = {{Quantitative detection of macular microvascular abnormalities identified by optical coherence tomography angiography in different hematological diseases}}, url = {{http://dx.doi.org/10.1038/s41598-024-76753-8}}, doi = {{10.1038/s41598-024-76753-8}}, volume = {{14}}, year = {{2024}}, }